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ABSTRACTA
ªOBJECTIVE: To describe the process used to identify the rec-
ommended core set of quality measures as mandated by the
Children’s Health Insurance Program Reauthorization Act of
2009 (CHIPRA) and provide an overview of the measures
selected.
METHODS: In May 2009, the multidisciplinary Agency for
Healthcare Research and Quality (AHRQ) National Advisory
Council for Healthcare Research and Quality Subcommittee
on Children’s Healthcare Quality Measures for Medicaid and
CHIP Programs (SNAC) was formed. The SNAC established
criteria to evaluate quality measures on the basis of their valid-
ity, feasibility, and importance. Subsequently, AHRQ imple-
mented a measure nomination process. Nominators supplied
key information related to measure validity, feasibility, and
importance. Oxford Centre for Evidence-Based Medicine
(CEBM) criteria were used to assess evidence supporting the
validity/scientific soundness of nominated measures. SNAC
members applied an adaptation of the RAND-UCLA modified
Delphi process to all nominated measures. Measures passing
the Delphi process were further assessed on the basis of criteria
pertaining to legislative priorities.
RESULTS: Seventy of 119 nominated measures met criteria for
validity, feasibility, and importance according to Delphi
scoring. After further prioritization, 25 measures were recom-
mended for the initial core set. Twelve of the recommended
measures focus on preventive care and health promotion
including prenatal/perinatal care (4), well-child care (1),CADEMIC PEDIATRICS
2011 Elsevier Inc. All rights reserved. S11immunizations (2), screening for: developmental delays (1),
obesity (1), and sexually transmitted infections (1), and receipt
of preventive dental services (2). Five acute care measures were
recommended which focus on management of upper respiratory
illnesses (2), receipt of acute care dental services (1), emer-
gency department utilization (1), and inpatient rates of central
line associated bloodstream infections (1). Five of the recom-
mended measures focus on chronic care, specifically asthma
(1), attention-deficit/hyperactivity disorder (1), diabetes (1),
and care for children with mental health conditions (2). Two
of the measures focus on family experiences with care, and
one of the measures assesses utilization of outpatient primary
care services. Thirteen (52%) of the measures were derived
from the National Committee for Quality Assurance (NCQA)
Healthcare Effectiveness Data and Information Set (HEDIS).
Eighteen of the measures were supported by relatively high
levels of evidence (Oxford CEBM grade A or B).
CONCLUSIONS: An open national public process combined
with an evidence-informed evaluation methodology resulted
in identification of a balanced, grounded, and parsimonious
core set of measures that should become feasible to implement
on a widespread scale over time.KEYWORDS: children’s health care quality measurement;
CHIP; CHIPRA; Medicaid
ACADEMIC PEDIATRICS 2011;11:S11–S21WITH THE PASSAGE of the Children’s Health Insurance
Program (CHIP) legislation in 1997 (Public Law 105-33),
Congress made their first commitment to developing
quality-of-care performance measures to assess the care
provided to children under this program.1 However, as
illustrated by deLone and Hess in this supplement,2
interpretation of the requirements in that legislation has
resulted in wide variation in state approaches to qualitymeasurement and a limited number of measures that can
be compared across states. Further, a recently released
annual report from the Secretary of Health and Human
Services (HHS) on the Quality of Health Care for Children
in Medicaid and CHIP noted that the Center for Medicare
and Medicaid Services (CMS) has no uniform system for
assessing quality of care for children across states.3
Concerns at the federal level related to this lack ofVolume 11, Number 3S
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inclusion of several specific provisions in the Children’s
Health Insurance Program Reauthorization Act (CHIPRA)
legislation of 2009 aimed at addressing these deficits.
These provisions included that the secretary identify
a core set of children’s healthcare quality measures for
voluntary use by states starting in December of 2011.4THE LEGISLATION
Title IV of CHIPRA (Public Law 111-3) required the
Secretary of HHS to identify and post for public comment
by January 1, 2010, an initial recommended core set of chil-
dren’s health care quality measures for voluntary use by
CHIP, health insurance issuers and managed care entities
that enter into contracts with such programs, and providers
of items and services under such programs. The legislation
called for identification of “existing quality of care
measures for children that are in use under public and
privately sponsored health care coverage arrangements or
are part of reporting systems that measure both the presence
and duration of health insurance coverage over time.”4
The legislation specifically called for identification of
measures on the following topics, although others could
be included: duration of enrollment and coverage; preven-
tive and health promotion services; treatment and manage-
ment for acute and chronic conditions in children; family
experiences of care, most integrated health care settings;
and availability of services. CHIPRA also called for
evidence-based measures and measures that could identify
disparities in health care quality by race and ethnicity,
socioeconomic status, and special health care need.AHRQ/CMS PARTNERSHIP
In response to this legislative directive, the Agency for
Healthcare Research and Quality (AHRQ) and the Centers
for Medicare &Medicaid Services (CMS) signed a Memo-
randum of Understanding giving AHRQ leadership
responsibilities for identifying the initial core set, working
in close partnership with CMS. CMS has the authority for
implementation of all CHIPRA provisions.
We present a brief summary of the processes used to
identify an initial recommended core set of children’s
health care quality measures and the key steps that will
need to be taken to successfully implement them on awide-
spread scale.METHODS
The initial core set of children’s health care quality
measures for voluntary use by Medicaid and CHIP was
developed by means of a transparent and evidence-
informed process that included broad input from multiple
stakeholders (Figure 1). Key components included
multiple opportunities for public comment; an AHRQ
National Advisory Council on Healthcare Research and
Quality (NAC) Subcommittee (SNAC) that contributed
expertise on validity, feasibility, and importance of
measures in use; and supportive background work byAHRQ, CMS, members of the CHIPRA Federal Quality
Workgroup (FQW),5 as well as authors of other papers
included in this supplement.
ESTABLISHMENT OF THE SNAC
As one of the first steps in the process of identifying the
recommended core set of measures, the AHRQ director
approved a charter creating the SNAC. The AHRQ NAC
had agreed to provide advice to AHRQ and CMS to facil-
itate their work to recommend an initial core set of
measures of children’s health care quality for Medicaid
and CHIP programs. To provide the requisite expertise
and input from the range of stakeholders identified in the
CHIPRA legislation, the NAC established the SNAC.
The SNAC was charged with providing guidance on
measure evaluation criteria to be used in identifying an
initial core measurement set, providing guidance on
a strategy for gathering additional measures and measure
information from state programs and others, and reviewing
and applying criteria to a compilation of measures
currently in use by Medicaid and CHIP programs to begin
selection of the initial core measurement set. SNAC recom-
mendations were to be provided to CMS and the NAC,
which in turn would advise the Director of AHRQ. The
Directors of AHRQ and CMS would then review and
decide on the final recommended core set to be presented
to the Secretary of HHS for consideration.
Nominations for SNAC members to represent the range
of stakeholders were sought from CMS and the CHIPRA
FQW.6 Emphasis was placed on including Medicaid and
CHIP officials because of their unique role as potential
implementers of the initial core set. Four state Medicaid
program officials (from Alabama, Minnesota, Missouri,
and the District of Columbia) and one state CHIP official
(from Alabama) were able to participate. Others repre-
sented Medicaid, CHIP, and other state programs more
generally (ie, representatives of the National Academy
on State Health Policy, National Association of State
Medicaid Directors, and the Association of Maternal and
Child Health Programs).
Representatives of health care provider groups came
from the American Academy of Family Physicians, Amer-
ican Academy of Pediatrics, American Board of Pediatrics,
the National Association of Children’s Hospitals and
Related Institutions, the National Association of Pediatric
Nurse Practitioners, and aMedicaid health plan representa-
tive. The interests of families and children were repre-
sented by the March of Dimes. Individual SNAC
members provided expertise in children’s health care
quality measurement, children’s health care disparities,
tribal health care, pediatric dental care, substance abuse
and mental health care, adolescent health, and children’s
health care delivery systems in general. Two members of
the NAC also participated in the SNAC.
The SNAC held 2 public meetings and accomplished
a substantial amount of work outside the meetings in order
to provide recommendations to the NAC, AHRQ, CMS,
and the HHS Secretary to meet the CHIPRA legislative
deadline of January 1, 2010.7
Figure 1. Process of identifying an initial, recommended core set of children’s health care quality measures for use by medicaid and CHIP
programs.
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Multiple ongoing opportunities for public input were
provided as part of this process. Early on, AHRQ estab-
lished a Web site to provide information on its role in
CHIPRA implementation, in close collaboration with
CMS, and an e-mail address through which the public
could comment on the process. In addition, both SNAC
meetings were open to the public and provided opportunities
for formal public comments. A conference call for members
of the Medicaid Medical Directors Learning Network was
also conducted to seek input on the measure identification
and nomination process. Several members of the network
responded by nominating children’s health care quality
measures in use by their states for consideration for the
initial core measure set.
Those making public comments through these mecha-
nisms included individual health care practitioners,
additionalMedicaid andCHIP programofficials, representa-
tives of professional societies and industry groups, child and
family advocates, and members of the CHIPRA FQW.
FIRST SNAC MEETING
This section describes preparation for the first SNAC
meeting, the focus of SNAC discussions, presentations to
the SNAC, refinements to methodology made during the
meeting, and the identification of a preliminary group of
measures to further consider for inclusion in the final core
set, as well as needs for additional information and work.PREPARATION
Seventy-seven measures in use by Medicaid and CHIP
programs were identified by AHRQ staff, with the
assistance of CMS, and a process for initial evaluation of
those measures was agreed upon by the SNAC co-chairs,
AHRQ, CMS, and the FQW.
The SNAC co-chairs, working through AHRQ, provided
subcommittee members with standard definitions and
criteria recommended for use in evaluating the validity
and feasibility (including reliability) of quality measures
(Table 1). SNAC members were asked to apply these eval-
uation criteria to the 77 measures using the RAND-UCLA
modified Delphi method.8 Previous work has shown this
method of evaluating quality measures to be reliable and
to have content, construct, and predictive validity in other
applications.9–11
The modified Delphi process involved individual SNAC
members scoring the initial identified set of Medicaid and
CHIP quality measures separately for validity and feasi-
bility on a 1- to 9-point scale (1 ¼ measure not valid or
feasible; 9 ¼ measure definitely valid or feasible). Objec-
tive information (eg, on underlying scientific soundness of
the measures) related to both measure validity and feasi-
bility was provided to the extent it was available. However
some measures were scored in this first round without
adequate identification of numerators, denominators, or
measure specifications, all of which are essential for
evaluating feasibility of measure implementation.
Table 1. Evaluation Criteria Used in Delphi Round I to Assess Validity and Feasibility of CandidateMeasures for the Recommended Core Set
A Quality Measure Should be Considered Valid If:
1. There is adequate scientific evidence or, where evidence is insufficient, expert professional consensus to support the stated relationship
between:
 Structure and process (eg, that there is a demonstrated likelihood that a clinical decision support system [a structural or capacity
measure] in a hospital or ambulatory office leads to increased rates of appropriate flu vaccination in the hospital or practice).
 Structure and outcome (eg, higher continuity of care in the outpatient setting [influenced by how appointments are organized] is
associated with fewer ambulatory care sensitive hospitalizations [eg, hospitalizations for dehydration]).
 Process or structure and outcome (eg, that there is a demonstrated likelihood that prescribing inhaled corticosteroids [a clinical
process] to specified patients with asthma will improve the patients’ outcomes and vice versa (eg, if we measure health outcomes there is
a sufficient demonstrated likelihood that the outcomes can be attributed to either clinical processes of care or health care delivery
structures or a combination of both).
2. The health care system can be said to be responsible for performance and/or the related health outcome. The majority of factors that
determine adherence to ameasure are under the control of the clinician, clinic, hospital, health plan, or theMedicaid or CHIP program subject
to measurement.
A Quality Measure Should be Considered Feasible If:
1. The information necessary to determine adherence to the measure is likely to be found in available data sources (eg, administrative billing
data, medical records, or routinely collected survey data).
2. Estimates of adherence to the measure based on available data sources are likely to be reliable and unbiased. Reliability is the degree to
which the measure is free from random error.
CHIP ¼ Children’s Health Insurance Program.
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scores for validity could be guided by professional
consensus when published evidence to support the
measure’s validity was insufficient.
The RAND-UCLA modified Delphi method outlines
cut points for passing scores on validity and feasibility.
For validity, the median passing score used is more strin-
gent, ie, 7–9 on the 9-point scale, than the passing score
for feasibility, which requires a median score of
4–9. The rationale for this difference is that for validity,
the evidence or expert consensus that exists to support
the assessment of the measure is relatively objective. Feasi-
bility is a more subjective and variable assessment than val-
idity. Some Medicaid or CHIP programs may find
a measure quite feasible to implement (due to their infra-
structure, amount of available funding, etc), while others
will not. Feasibility of implementing a quality measure
can also be field tested. If it is determined that a measure
is less feasible to implement than initially assumed, needed
technical assistance could be provided by CMS, or the
measure might be dropped from the core set.
Nineteen (70%) of the 27 SNAC members participated in
the first round ofDelphi scoring.Median scores and a display
of the distribution of scores across voting members were
calculated and prepared for SNAC review by AHRQ staff
before the first meeting. The median scores summarized
the individual scores of SNACmembers on these 2 domains
(ie, validity and feasibility). The median scores were used to
determine whether candidate measures would be discussed
further at the meeting. Twenty-five measures passed with
sufficient scores to be noncontroversial. Measures with
a median validity score of 6 or 7, a median feasibility score
$4, and a relatively wide distribution of scores across
members, suggesting little consensus among the group,
were discussed by the SNAC. These measures were selected
for discussion because they were deemed controversial and
in need of further consideration by the group. Forty-five of
the originally identified 77 measures in use by Medicaid
or CHIP programs met these scoring criteria.FIRST SNAC MEETING
Presentations by the AHRQ Director, CMS’s Director of
the Center for Medicaid, CHIP, and Survey & Certification
(CMCS), and Director of the Division of Evaluation, Quality,
and Health Outcomes in CMCS set the stage for the
meeting.12,13 The AHRQ director provided the charge to the
SNAC, and the CMCS director expressed a strong desire
for the SNAC to recommend a grounded and parsimonious
core set of measures that could be implemented voluntarily
by state programs, health plans, and provider groups.
The SNAC spent a large part of this first meeting review-
ing the criteria for validity and feasibility used in Delphi
Round I, identifying criteria for importance, and discussing
the measures that were deemed controversial after Delphi
Round I.
REFINEMENTS TO THE MEASURE EVALUATION
METHODOLOGY
The refinement process involved reviewing, discussing,
and reaching consensus on criteria the SNAC would use
to evaluate the validity and feasibility (including reli-
ability) of candidate measures in future rounds of the
Delphi process.14
In addition, importance was added as a third domain,
along with validity and feasibility, to consider when evalu-
ating potential measures. The SNAC worked to establish
consensus on the criteria to be used to rank the importance
of measures under consideration. To be considered impor-
tant, the measure had to meet at least some of the following
criteria. The criteria are listed in order of decreasing weight
as determined through a voting process by SNACmembers:
 The measure should be actionable. State Medicaid and
CHIP programs, managed care plans, and relevant health
care organizations should have the ability to improve
their performance on the measure with implementation
of quality improvement efforts.
 The cost to the nation for the area of care addressed by
the measure should be substantial.
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the quality problem assessed by the measure.
 The extent of the quality problem addressed by the
measure should be substantial, ie, a significant propor-
tion of the US child population should be affected by
poor performance on the measure.
 There should be documented variation in performance
on the measure.
 The measure should be representative of a class of
quality problems, ie, it should be a “sentinel measure”
of quality of care provided for preventive care, mental
health care, dental care, etc.
 The measure should assess an aspect of health care
where there are known disparities.
 The measure should contribute to a final core set that
represents a balanced portfolio of measures that is
consistent with the intent of the legislation.
 Improving performance on measures included in the
core set should have the potential to transform care for
our nation’s children.
Similar to feasibility, the threshold for a passing score on
importance was also set at$4 on the 9-point Delphi scale.
The SNAC chose this cut point because the necessary
information to objectively assess these criteria may not
be available in all cases, and some of the criteria were
deemed somewhat subjective in nature (eg, whether
improvement on the measure would “transform care”).
The SNAC members were asked to score each of the 25
measures that had unequivocally passed the first round of
Delphi scoring for validity and feasibility on the new crite-
rion of importance. AHRQ staff then summarized these
scores using the median value.
OTHER STEPS AND DECISIONS
The SNAC’s discussion of the 45 controversial
measures resulted in the recommendation that further
information related to measure validity, feasibility, and
importance would be needed before further consideration
of the measures. The SNAC also determined that a call for
nominations of additional pediatric quality measures in
use (either within or outside of Medicaid and CHIP
programs) should be used to identify a larger set of
measures to consider for the final core set. AHRQ staff
were asked to identify relevant information related to val-
idity, feasibility, and importance on the controversial
measures. SNAC members agreed to nominate additional
measures in use.
SNACmembers expressed a strong desire to recommend
a grounded and parsimonious core set of measures that
could be implemented voluntarily by state programs,
health plans, and provider groups, and they agreed on
a target number of no more than 25 measures. The SNAC
acknowledged that such a core set would be incomplete,
but efforts would be made to balance the set to accomplish
the legislative goals and the goals articulated in the SNAC
discussion of measure importance. The SNAC agreed to
bring forth to the NAC’s attention measures not accepted
into the core set. Furthermore, SNAC members agreed toidentify important aspects of child health for which valid
measures may not currently exist.
ADDITIONAL INPUT AND DISCUSSION
Representatives from the National Quality Forum, the
National Committee on Quality Assurance, and the Center
for Health Care Strategies also spoke at the meeting on the
challenges of implementing health care quality measures
for children. In addition, several expertswho had been asked
to write federally supported papers on specific aspects of
measurement in the legislation presented their early
thoughts about their work. These experts addressed the
charges to them of conceptualizing and assessing the valid-
ity, feasibility, and importance of measures of mental and
behavioral health care, family experiences of care, duration
of enrollment and coverage, availability of services, and the
“most integrated health care setting.” AHRQ and CMS also
asked that papers be prepared analyzing data sets of the
National Academy for State Health Policy, Health Manage-
ment Associates, and the Child and Adolescent Health
Measurement Initiative database from the 2007 National
Survey on Children’s Health.15 Some of the final papers
and their key findings are included in this supplement.PREPARATION AND THE SECOND SNAC MEETING
In addition to being open to public participation on site,
the second meeting was Webcast allowing for greater
participation and public comment.16
ADDITIONAL MEASURE NOMINATIONS
AHRQ staff, in collaboration with the SNAC co-chairs,
developed a measure nomination template.17 This template
was created in order to collect a standardized set of infor-
mation on all measures nominated for potential inclusion
in the core set. The nomination template was made avail-
able for approximately 1 month before the second meeting.
In addition to measure nominations by SNAC members,
public nominators included members of the Medicaid
Medical Directors Learning Network, the American
Medical Association Physician Consortium for Perfor-
mance Improvement, the National Partnership for Women
and Families, and the Child and Adolescent Health
Measurement Initiative on behalf of The Commonwealth
Fund. Additional nominations were obtained through
e-mail to the AHRQ public comment e-mail address.
CHIPRA FQW nominations also came from CMS and
the Health Resources and Services Administration.
In addition to all newly nominated measures, each
measure that either passed Delphi Round I (25 measures)
or was considered controversial by the SNAC during their
first meeting in July (45 measures) was entered into the
measure template, with required information, by AHRQ
staff. Authors of the CHIPRA-commissioned papers (pre-
sented in this supplement) also recommended 4 measures
for consideration and additional sources of data for quality
measurement on the basis of their works in progress.
At a minimum, nominators were asked to identify
the measure numerator and denominator, measure
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was then supplemented with additional information where
necessary by AHRQ staff and the SNAC co-chairs. Through
this work, a standardized set of information was made
available for almost all measures for consideration by the
SNACmembers during their second roundofDelphi scoring.
A 1-page summary sheet was developed for each measure
under consideration that included abstracted information
from the measure nomination template and a summary of
the evidence base for the measure’s underlying scientific
soundness using the Oxford Centre for Evidence-Based
Medicine (CEBM) criteria (Table 2).18
In total, the SNAC had 119 measures to consider during
a second modified Delphi process.DELPHI ROUND II SCORING BY THE SNAC
Members were sent the 1-page summary sheets for the
119measures under consideration and a scoring instruction
guide.14 By means of a second modified Delphi process, 19
(70%) of 27 SNAC members participated in scoring. The
scoring process resulted in selection of 65 of the 119
measures as meeting criteria for validity, feasibility, and
importance when we strictly adhered to the preset cutoff
points. As in Delphi Round I, SNAC members were told
they could use professional consensus on the underlying
scientific soundness of the measures in cases of insufficient
published evidence.
SNAC MEETING DELIBERATIONS
As a result of time constraints and the need to identify
for AHRQ and CMS consideration a reasonable core set
of measures near the SNAC’s target number of 25, the
initial plan was to discuss and consider only the 65
measures that passed the second modified Delphi scoring
process as candidates for the core set. However, initial
discussions at the meeting resulted in adding back 5
measures that did not strictly pass the second Delphi round
(ie, those with high median feasibility and importance
scores [>7] and median validity scores of 6 or 6.5 rather
than the cutoff of 7) to the list of measures to be discussed
and voted on during the meeting. Thus, 70 of the 119
measures scored in Delphi Round II were discussed and
considered for the core set at the meeting.19,20
ELECTRONIC VOTING PROCESS
Throughout the meeting, a method of confidential elec-
tronic voting was used extensively by SNAC members.
This method was chosen because in small groups some
members may dominate a discussion, leading to group
decisions that do not reflect the true sense of the group
membership.21 Through private electronic voting, the
SNAC process was most likely to obtain the candid
individual preferences of members, accumulating to
a consensus of the SNAC.
BALANCING MEASURES ACROSS MULTIPLE DOMAINS
The SNAC reviewed and prioritized measures on the
basis of several characteristics pertaining to legislativeand feasibility criteria, including: data source (administra-
tive, medical record, electronic health records, other health
information technology, or survey); site of care (primary
care, specialty care, inpatient, emergency, mental health,
substance abuse, dental); measure type (outcome, process,
structural); care continuum (screening, prevention, diag-
nosis, treatment, care coordination); accountable entity
(state, program, health plan, provider); child ages to which
the measure applied; and availability of data to report
disparities.
ELIMINATION OF OVERLAPPING MEASURES, MERGING
OF SOME MEASURES, AND VOTING
SNAC members engaged in detailed discussions of
measures felt to have substantial overlap. For example,
multiple measures pertaining to healthy birth (including
the prevention of premature birth) passed the criteria for
validity, feasibility, and importance, as did multiple dental
measures. After discussions were completed, a series of
votes was conducted which resulted in elimination of
multiple measures and merging of some measures within
a given category. For example, 3 separate well-child care
visit measures that apply to different age groups were
combined into one measure for voting purposes. Similarly,
a number of measures of the quality of services to promote
healthy birth were eliminated, narrowing measures in this
area to 4, including one outcome measure (low birth
weight). Measures in each legislative category or subcate-
gory (eg, prevention/health promotion, care of children
with chronic disease) were rank ordered within the
category or subcategory. Lowest scoring measures were
eliminated from further consideration. This process
resulted in 31 measures for final consideration.
GETTING TO 25 MEASURES TO RECOMMEND
TO THE AHRQ NAC
Three rounds of voting were conducted in succession on
the 31 remaining measures. SNACmembers could vote for
their top 20 measures out of the 31 that remained. In round
1, members individually voted for their top 10 measures; in
round 2 their next 5 measures; and in round 3 their final 5
measure choices. Measures voted for in the first round
received 3 points per vote, measures voted for in the second
round received 2 points per vote, and measures voted for in
the third round received 1 point per vote. A priority score
was then calculated for each measure that represented the
total points assigned to that measure by SNAC members
after the 3 rounds of voting. The final rank order of the
measures based on priority scores was examined by the
SNAC to assess how the acceptance of various cut-points
(ie, 10, 15, 20, 25 total measures) would fulfill the goal
of arriving at a grounded, parsimonious, balanced core
set of measures.22RESULTS
Among the 119 measures nominated for consideration
by the SNAC, information needed to assess the validity,
Table 2. Oxford Centre for Evidence-Based Medicine (CEBM) Evidence Grades
Evidence Grade Definition of Grade Definition of Study Type
A Consistent level 1 studies Level 1: Randomized controlled trials
B Consistent level 2 or 3 studies or extrapolations* from level
1 studies
Level 2: Cohort studies; outcome
research
Level: 3: Case-control studies
C Level 4 studies or extrapolations from level 2 or 3 studies Level 4: Case series
D Level 5 evidence or troublingly inconsistent or inconclusive
studies of any level
Level 5: Expert consensus opinion
*Extrapolations are where data are used in a situation that has potentially clinically important differences compared to the original study
situation.
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in some cases (Table 3).
The SNAC ultimately voted to recommend 25 measures
(Table 4), including 12 for prevention/health promotion, 5
for acute care, 5 for chronic condition management, 2 to
assess family experiences of care, and 1 focused on avail-
ability of services. These represent a set of measures that
address care across multiple settings (ambulatory [primary
care, specialty care], emergency department, and inpa-
tient); multiple conditions (pregnancy, vaccine-preventable
conditions, sexually transmitted infections, overweight,
social and behavioral developmental delays, dental care,
appropriate antibiotic use for respiratory conditions,
asthma, diabetes, and mental health); and multiple ages
(in utero, newborn, early childhood, school age, and
adolescence). The well-child care visit, general screening,
and family experiences of care measures are relevant to all
37.3 million children enrolled in Medicaid or CHIP.11
Although some measure topics address conditions with
relatively low prevalence (eg, children with diabetes, chil-
dren with central lines hospitalized in intensive care units),
the costs of inadequate or unsafe treatment for these
children are high.
In terms of levels of evidence for underlying scientific
soundness of the measures (Table 2), 2 measures are
Oxford CEBM grade A (8%), 14 are grade B (56%), 2
are both B and D (8%), 1 is grade C (4%), 3 are grade D
alone (12%), and 3 could not be graded (12%) as a result
of insufficient evidence available to make this assessment.
Thirteen (52%) of the measures are currently National
Committee for Quality Assurance (NCQA) Healthcare
Effectiveness Data and Information Set (HEDIS) measuresTable 3. Characteristics of the Nominated Measures Related to
Validity, Feasibility, and Importance Criteria (N ¼ 119)
Criteria n (%)
Missing information
No specifications 26 (22)
No reliability data 59 (50)
No validation data 42 (35)
No disparities data 76 (64)
Not in use 29 (24)
Evidence grade
A 18 (15)
B 58 (49)
C 3 (3)
D 26 (22)
No evidence/unable to grade 14 (12)reported by Medicaid managed care plans; 2 are CMS–
Early Periodic Screening, Diagnosis, and Treatment
(EPSDT) program measures (both dental); 3 are measures
submitted by individual state Medicaid or CHIP programs;
2 are measures developed by the American Medical Asso-
ciation Physician Consortium for Performance Improve-
ment; 1 is a measure used by state Medicaid programs
under a grant program; 1 is a measure derived from
national vital statistics using state birth certificate data; 1
as nominated is stewarded by the California Maternal
Quality Collaborative; and 1 is a measure used by the
National Health Safety Network at the Centers for Disease
Control and Prevention (Table 4).
Ten of the measures as nominated currently use a hybrid
of administrative and medical records data, 8 require
administrative data only, one uses a combination of
Medicaid enrollment data and state birth certificate data,
one uses survey data, and others use other combinations.
Information on the sources of data for some measures
was not provided.
All but 3 of the SNAC-recommended measures were
accepted by HHS for posting for public comment.23 The
deleted measures were “child and adolescent suicide risk
assessment” (not in current use, except as a Physician
Quality Reporting Initiative pilot measure for adults)24;
the Consumer Assessment of Healthcare Providers and
Systems (CAHPS) Clinician and Group Survey (insuffi-
cient documented experience in pediatric care for
Medicaid and CHIP enrollees); and the NCQA HEDIS
annual dental visit measure (more useful information
provided by the EPSDT measures of preventive and treat-
ment services; EPSDT measures already reported by
Medicaid programs and future requirement for CHIP
programs [CHIPRA requirement]). In addition, HHS
decided to list the 3 well-child care visit measures individ-
ually. These changes resulted in a total of 24 measures
being posted for public comment.23DISCUSSION
Taken together as a set, the measures are relevant to eval-
uate the quality of many aspects of care for all 37.3 million
children enrolled in Medicaid or CHIP.11 The work of the
SNAC represents a survey of currently available measures,
careful evaluation of available evidence, and expert judg-
ment to create a grounded and parsimonious core measure-
ment set, all done in a publicly transparent way.
Table 4. SNAC-Recommended Initial Core Set of Children’s Health Care Quality Measures, Grouped by Legislative Topic*
Legislative Topic Area/Subtopic/Brief Measure Label
Current Measure
Steward
Prevention and Health Promotion
Prenatal/perinatal
Frequency of ongoing prenatal care NCQA
Timeliness of prenatal care NCQA
Percentage of live births weighing less than 2500 g NVSS
Cesarean rate for low-risk first-birth women CMQC
Immunizations
Immunizations for 2-year-olds NCQA
Adolescent immunization NCQA
Screening
Body mass index documentation for 2–18-year-olds NCQA
Rates of screening using standardized screening tools for potential delays in social and emotional development None†
Chlamydia screening for 16–20-year-old women NCQA
Well-child care
Well-child visits include 3 NCQA measures combined into one measure: 1) well-child care visits in the first
15 months of life; 2) well-child care visits in years 3, 4, 5, and 6 of life; 3) adolescent well-child care visits
NCQA
Dental
Total eligible to receive preventive dental services (EPSDT measure Line 12B) States/CMS
Annual dental visit NCQA
Management of Acute Conditions
Upper respiratory—appropriate use of antibiotics
Pharyngitis—appropriate testing NCQA
Otitis media with effusion—avoidance of inappropriate use of systemic antimicrobial drugs AMA/PCPI
Dental
Total EPSDT eligibles who received dental treatment services (EPSDT CMS Form 416 Line 12C) States/CMS
Emergency department
Emergency department utilization—average number of emergency room visits per member per reporting period S/ME
Inpatient
Pediatric catheter-associated bloodstream infection rates (PICU and NICU) Hospitals/CDC
Management of Chronic Conditions
Asthma
Annual number of asthma patients (>1 year old) with >1 asthma-related emergency room visit S/AL
ADHD
Follow-up care for children prescribed ADHD (medication continuation and maintenance phase) NCQA
Mental health
Child and adolescent major depressive disorder—suicide risk assessment AMA/PCPI
Follow-up after hospitalization for mental illness NCQA
Diabetes
Annual hemoglobin A1C testing (all children and adolescents diagnosed with diabetes) S/AL
Family Experiences With Care
HEDIS CAHPS Medicaid 4.0 including supplemental items for children with chronic conditions NCQA
CAHPS Clinician and Group Survey for primary care practitioners participating in Medicaid and CHIP CAHPS
Availability of Services
Access to primary care practitioners, by age and total NCQA
*NCQA¼National Committee for Quality Assurance; NVSS¼National Vital Statistics System; CMQC¼CaliforniaMaternal Quality Collab-
orative; EPSDT ¼ Early Periodic Screening, Diagnosis, and Treatment; CMS ¼ Centers for Medicare & Medicaid Services; AMA/PCPI ¼
American Medical Association Physician Consortium for Performance Improvement; S/ME ¼ State of Maine; PICU ¼ pediatric intensive
care unit; NICU ¼ neonatal intensive care unit; ADHD, attention-deficit/hyperactivity disorder; CDC ¼ US Centers for Disease Control and
Prevention; S/AL ¼ State of Alabama; CAHPS ¼ Consumer Assessment of Healthcare Providers and Systems.
†Developed with support from The Commonwealth Fund, which is also supporting implementation and testing in state Medicaid programs
and elsewhere. States have different data collection strategies.
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a group, it is critical to note a number of themes identified
by the SNAC, Medicaid and CHIP officials, and the public.
WHAT THIS PROCESS ACCOMPLISHED
The initial recommended core set and its voluntary im-
plementation provide a solid first step that will allow for
progression toward the stated CHIPRA goal of establish-
ing a measurement system that allows for feasible and
valid comparisons of child health care quality across
all populations, states, programs, and providers. Therecommended list of measures (and the compilations of
measures fromwhich it was drawn) represents a significant
achievement of a number of persistent and talented
communities: those intensely engaged in measuring and
improving health care quality; child health researchers;
child health advocates; state public program officials;
representatives of Federal programs that support the
development and dissemination of children’s health care
quality measures; and many others. The process of identi-
fying the core measurement set brought together the
expertise of these talented but formerly fragmented groups
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legislation.
WHAT THE PROCESS DID NOT DIRECTLY ADDRESS:
CHALLENGES OF IMPLEMENTATION
In relation to the multiple health care needs of children
and the CHIPRA legislation measurement domains, the
initial recommended core set of 25 measures may seem
relatively small. However, to many who are being asked
to implement the measures, the number may seem quite
large. It is clear that implementation will not be automatic,
and the number of measures in the recommended initial
core set should be considered in the overall context of
the CHIPRA legislation and other legislative and Federal
Executive Branch initiatives, as well as in the context of
the economic crisis faced by most states.25
By law, measures in the core set are intended for volun-
tary use; states, health plans, and providers are not required
to use them. CMS will assist states by identifying standard
measure specifications and providing focused, tailored
technical assistance on information systems and measure-
ment. States will receive a matching Federal Medical
Assistance Percentage for the “effective collection and re-
porting of measures.” With the implementation of the
American Recovery and Reinvestment Act of 2009 for
health ITadoption, state concerns about the burden of using
medical records for quality measurement should lessen
over time. Eligible providers will receive incentive
payments for “meaningful use” of measures and informa-
tion technology. Additional incentives for use of a core
set of measures with standardized specifications will
include the ability of states to benchmark their own perfor-
mance against aggregated data. Some states are already
using many of the measures identified for the initial core
set. Inevitably, implementation of the core measure set
will take place over time, using a carefully staged process.REFINEMENTS AND ENHANCEMENTS TO THE CORE
SET ARE NEEDED
Implementation of the recommended core set of
measures as currently specified will not be sufficient to
achieve the vision of a comparable, evidence-based, under-
standable set of measures that can identify racial and
ethnic, socioeconomic, and health condition disparities in
health care for children. In making its recommendations
for the initial core measure set, the SNAC emphasized
that the measures would need to be reconfigured to be
able to reflect children’s health care quality across all
Medicaid and CHIP programs, providers, consumers, and
intermediaries (eg, health plans contracting with state
Medicaid programs). Modifying the measures for a more
comprehensive set of programs and beneficiaries will
take time and resources.
One example of the need for modification is the NCQA
HEDIS measures, which make up a large proportion of the
initial, recommended core measure set. NCQA HEDIS
measures are currently used for reporting by Medicaid
managed care plans and, as currently specified, cannot beused for children enrolled in CHIP or children in states
with limited or no Medicaid managed care. In 2008, 51%
of children enrolled in Medicaid and CHIP (17 million
for Medicaid and 5.3 million for CHIP) were enrolled in
managed care organizations.26 Many states have no
managed care presence.
Other measures, specifically those that use data from
state birth certificates reported to the National Vital Statis-
tics System (NVSS), those used by nongovernment entities
(eg, California Maternal Quality Collaborative), and those
currently in use by selected states vary across states in
measurement methodology or do not appear to be in use
by states as currently specified.
WORK STILL TO BE DONE
Few of the proposed measures are currently used to
report data that distinguish care quality by race, ethnicity,
tribe, socioeconomic status, or special health care need
status among children, all of which are required by the
CHIPRA legislation and are critical in light of the
demographics of the US child population.27,28 Attention
to improving the capacity of measures and data sets to
assess disparities is needed. For all measures, a common
duration of enrollment calculation is essential to make
valid and reliable assessments of health care quality in
programs and populations and comparisons across and
within institutions, programs, and states. Additionally,
the SNAC agreed that it is critical to identify the
appropriate entities that should be held accountable for
health care quality in the multi-layered approach to care
delivery.29
In addition to the work needed on the initial core set of
measures, new measure development is needed in several
areas. The SNAC noted in particular the need for additional
measures of specialty care, inpatient care, substance abuse
care, and mental health treatment, as well as measures that
link mainstream clinical care with other services that chil-
dren receive (eg, coordination of care), health outcome
measures, and measures of the medical home.
Fortunately, CHIPRA provided support for advancing
and improving pediatric quality measures and called for
priorities to be set to guide a new pediatric quality
measures program. States are also encouraged to experi-
ment with and evaluate the core measure set using funds
from the CMS quality demonstration projects.30
LIMITATIONS
The efforts of the SNAC were limited to some degree by
the time available to arrive at the recommended core set of
quality measures. Some of the information the SNAC
needed to objectively assess the merits of nominated
measures was not available during their deliberations
(Table 3); as noted below, some information would not
be available for years, even assuming that action was taken
to develop the needed data. Similar efforts in the future
could be conducted over a longer timeframe, allowing for
establishment of consensus around measure evaluation
criteria before initiating any measure assessment activities.
Additionally, the call for measures, the nomination
S20 MANGIONE-SMITH ET AL ACADEMIC PEDIATRICSprocess, and the process of summarizing submitted infor-
mation could be completed before engaging in assessments
of the measures under consideration to increase efficiency
and decrease rework. That said, the abbreviated timeline
had its advantages, in that it helped focus the process and
sharpen deliberations. Past efforts to identify core sets of
measures, absent the CHIPRA requirements (eg, evidence
based, requirement for public posting in less than 10
months from passage of the legislation) while able to
make considerable progress, have not resulted in the
measurement consistency desired by many, including
some state programs.2,31–36
Other factors contributing to a less than ideal process
could not have been remedied with more time (unless
time was measured in years). These include the lack of
a timely and detailed compilation of health care quality
measures in use by state Medicaid and CHIP programs
(to identify measures in use) and the paucity of a research
base to establish the underlying scientific soundness for
many measures of the quality of services used or poten-
tially used bymanyMedicaid and CHIP enrollees (eg, peri-
natal services, mental health services, periodicity and
content of well-child care visits, coordination efforts, and
dental treatment).
HOW THE MEASURES COULD BE USED
If most states can overcome the aforementioned chal-
lenges to broad implementation of the core set of quality
measures, this measurement set will provide a method to
routinely assess our nation’s child health care quality by
means of standardized methods. The availability of these
national and local benchmarking data could facilitate iden-
tification of quality deficits at multiple different levels
where the core set of measures could be used (eg, health
care systems, health plans, health centers, and individual
providers). This routine measurement could inform and
hopefully drive quality improvement efforts at all of these
levels. That said, this list of 25 quality measures is far from
comprehensive. This lack of comprehensiveness may have
the unintended consequence of states, programs, health
plans, and providers focusing their improvement efforts
on this limited set of health care issues which may ulti-
mately take resources away from other areas of care that
need attention. However, even improvements for this
limited set of health care conditions would be a positive
first step toward improving the quality of care children
receive in the US. Implementation of this initial set of
measures should also allow organizations to establish the
necessary infrastructure to later implement a more compre-
hensive, expanded core set of measures, including those
developed under funding from the Pediatric Quality
Measures Program mandated by the CHIPRA and
administered through AHRQ.CONCLUSION
An open, national, public process combined with an
evidence-informed evaluation methodology resulted in
identification of a balanced, grounded, and parsimoniouscore set of recommended measures that should become
feasible to implement on a widespread scale over time.
As stimulated by CHIPRA and building on AHRQ’s,
CMS’s and the states’ long-standing interest in health
care quality improvement, HHS and the states are rejoining
their efforts to use these recommended measures to iden-
tify areas in need of improvement and monitor progress
toward the goal of a high quality health care system for
all children.
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